Half Year 2020 Capitol Health Ltd Earnings Call Transcript
Good morning, everyone, and welcome to the Capitol Health Half Year Presentation this morning from myself, Justin Walter, the Managing Director, and I have with me, Marcell Judkins, our Chief Financial Officer.
So we'll get straight into the deck and move to the executive summary. So just running through each key achievements and the highlights for the half year. With our revenue confirmed solid organic growth while reshaping the portfolio for increased profitability. We've seen an increase in revenue of $8.2 million, representing 11% growth year-on-year. Our net debt remains at $44.5 million, which allows for the purchase of FSR to remain under our covenants of 2x the net debt ratio at a Board level. We continue our dividend policy with an interim dividend declared at $0.005 per share fully franked. In the half year, we had a further investment in Enlitic and continued support for that product development and eventual rollout through our business. And excitingly as well, we opened up our Cranbourne Greenfield, which is going
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
